2 results
Approved WMOCompleted
To evaluate the safety and efficacy of subcutaneousbelimumab (GSK1550188) and intravenous rituximab coadministrationin subjects with primary Sjögren*s syndrome.
Approved WMOCompleted
Primary Objective: To compare peri-implant hard and soft tissue changes as measured on standardized intraoral radiographs and direct digital intraoral scans between the group of single final and and the group of multiple repeated abutment dis/re-…